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Summary
Introduction: Total disc replacement (TDR) has existed since 1984 but is not covered by the
French national healthcare system (Sécurité Sociale). The present study assessed clinical out-
comes, and also pre-, peri- and postoperative treatment costs.
Hypothesis: Surgical management of low back pain (LBP) provides medical and economic ben-
eﬁt.
Materials and methods: A prospective study recruited 19 patients in the Nice University Hospital
Center (France); mean age, 41 years; 15 female. Inclusion criteria were: age less than 60 years;
chronic low back pain (LBP) with single-segment discopathy; work related injuries and patients
not covered under the General provision of the Sécurité Sociale were excluded. VAS, Oswestry
and SF36 scores and return to work capability were analyzed. The local national health insurance
branch ofﬁce (Caisse Primaire d’Assurance Maladie [CPAM]) provided detailed coverage data
for a 39-month period around the operation.
Results: Revision surgery was required for one instance of vertebral fracture. Preoperative
follow-up was 14months, postoperative FU 21months and the perioperative period 4months.
LBP and quality of life showed improvement. Seventy-nine percent of patients reported satis-
faction, 59% returned to work, and 84% had leisure activity. Total CPAM payout (reimbursement)
was D 399,082. Daily sickness beneﬁt and disability compensation were the main cost items.
Mean TDR cost per patient was D 6833. Mean reimbursements were 19% lower post- than preop-
eratively. Pre- and postoperative clinical results did not correlate, while pre- and postoperative
reimbursement costs did, as did cost and postoperative clinical status (r =−0.72). Preoperative
cost was a predictive factor for postoperative clinical result.
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Discussion: TDR achieves favorable medicoeconomic results.
Level of evidence: III: case-control study.
. All
I
T
b
F
d
i
r
m
c
r
b
o
r
(
m
s
r
e
D
t
e
A
D
c
O
p
t
M
A
i
e
f
o
d
t
w
r
t
u
M
I
T
t
L
p
a
p
c
M
T
>
4
t
c
E
T
o
o
w
a
w
s
a
n
f
e
o
s
T
T
a
2
i
c
p
i
(
D
M
C
P
o
a
p
a
E
T
s
b
T© 2011 Elsevier Masson SAS
ntroduction
here is no medical consensus of the management of low
ack pain (LBP). Surgically, the reference attitude is fusion.
or the last 20 years, an alternative, in the form of total
isc replacement (TDR), has been available. Long-term clin-
cal results in TDR are encouraging, according to the series
eported by Lemaire et al. [1] and David [2].
The possible economic impact of TDR is not well deter-
ined. At the same time, the ﬁnancial context of health
are is a matter of heated debate, as expenditure is
estricted. The cost of surgical management thus needs to
e established, and also the size of the costs incurred post-
peratively.
A prospective series of patients was followed up, and the
eal long-term costs of national health insurance scheme
Sécurité Sociale) coverage (reimbursements) were deter-
ined.
The aim of the study was to assess the cost of medico-
urgical management before, during and after TDR and the
elation between cost and clinical and radiological param-
ters. The cost of the implant, with a unit price of about
3,000, for which insurance coverage is an issue, was also
aken into account. Is LBP improved, both medically and
conomically, by TDR?
The study was conducted with the help of the Provence-
lpes-Côte-d’Azur-Corse Regional Health Insurance Medical
epartment Authority (Direction Régionale du Service Médi-
al: DRSM) and the Alpes-Maritimes area Health Insurance
fﬁce (Caisse Primaire d’Assurance Maladie: CPAM) who
rovided ﬁnancial data on the exact amounts paid out (in
he form of reimbursements) by the Sécurité Sociale.
aterials and methods
continuous prospective descriptive study was run, with
nclusion from July 2004 to May 2006 and clinical and
conomic follow-up until September 2007. Surgery was per-
ormed in two departments (Orthopedics and Neurosurgery)
f the Nice University Hospital Center (France). Economic
ata were provided by the CPAM. Medicoeconomic and sta-
istical analysis was performed by an independent observer
ith the help of the hospital’s Medical IT Department. The
eliability of the data made this procedure seem preferable
o the interview-based economic data collection approach
sed during the ﬁrst year of the study.
aterials
nclusion criteria
he diagnostic inclusion criterion was degenerative discopa-
hy with chronic (> 6months) single-segment (L4L5 or L5S1)
BP. The age criterion was 20—60 years. Discography was
erformed in case of dual-disc involvement. Scintigraphy
nd biological assessment for infection were performed for
s
c
t
trights reserved.
reviously operated patients. Thirty patients meeting these
riteria were operated on between July 2004 and May 2006.
edical exclusion criteria
hese include work accidents and occupational diseases;
20◦ frontal or sagittal curvature abnormality; grade 3 or
posterior osteoarthritis; history of disc surgery of less
han 6months; compressive disc herniation with neurologi-
al deﬁcit or sequestration.
conomic exclusion criteria
hese include patients not covered by the General Scheme
f the Sécurité Sociale and those resident outside of France
r of the local administrative département.
Ten patients were excluded on economic criteria: four
ere resident in a different administrative département
nd one in a different country (Monaco). Four self-employed
orkers were covered by a different social health insurance
cheme, limiting access to economic data. For one patient,
lthough covered under the General provision, data were
ot available. Finally, one patient, considered an outlier
or requiring very costly complication related revision, was
xcluded from the economic analysis, and will be reported
n elsewhere. Nineteen patients thus met economic inclu-
ion criteria.
he series
he medicoeconomic series comprised 19 patients: ﬁve male
nd 14 female patients, with a mean age of 41 years (range,
4—53 yrs). Only three patients had history of disc surgery
n the form of discectomy of the involved segment. Mean
linical follow-up was 25months (range, 14—35months). All
atients received single-segment TDR: L5S1 in 11 cases, L4L5
n eight. Four types of implant were used: eight SB Charité III
®Link-Depuy), six MOBIDISC (®LDR), three OMAV (®Sofamor
anek-Medtronic) and two PRODISC (®Aesculap-Synthes).
ethods
linical assessment
ain was assessed on a visual analog scale (VAS) and quality
f life (QoL) on self-administered questionnaires (Oswestry
nd SF36). Satisfaction scores and ability to return to occu-
ational and personal (household, sports or else leisure)
ctivity were recorded.
conomic assessment
DR implants are not covered by the French Sécurité Sociale
cheme, and were purchased using a dedicated D 63,000
udget approved by the hospital’s Innovation Commission.
he patients’ written informed consent to the economic
tudy was obtained and the administrative departments
oncerned with national health insurance payouts were con-
acted; agreements were signed with the regional DRSM and
he local CPAM.
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RAgreement was obtained from the French Information
protection Agency (Commission Nationale de l’Informatique
et des Libertés [CNIL]) to establish a medical database
including personal information. Data covered a 39-month
period around surgery for all patients. A data request to
the accounts archive of the Sécurité Sociale retrieved the
amounts paid out for the patients between March 1st, 2004
and May 23rd, 2007. For each patient, there were three
unequal periods of follow-up (Fig. 1) according to their inclu-
sion date, whereas the economic follow-up period was the
same for all.
The preoperative period ran from March 1st, 2004 to
1month before TDR; it lasted a mean 13.2months (range,
3—24months), and reﬂected the costs incurred for a non-
operated chronic LBP patient. The perioperative period ran
from 1month preoperatively to 3months postoperatively;
it systematically lasted 4months and reﬂected the costs
entailed by the decision to operate: preoperative assess-
ment, hospital stay around the operation, postoperative
rehabilitation and systematic discharge medication up to
month 3. This approximated the real cost of medicosurgical
management. The postoperative period ran from the ﬁrst
day of the fourth postoperative month to May 23, 2007, for
a mean 21.5months (range, 11—32months), and reﬂected
the costs incurred after surgery for a chronic LBP patient
operated on by TDR.
Amounts invoiced were subdivided into four cost cate-
gories:
• hospital stay, including all acts invoiced with the estab-
lishment’s code-number;• daily sickness beneﬁt paid out during sick leave and, at
the end of the period of cover, disability compensation
if the patient was entitled to this and did not return to
work;
C
T
ehealth care charges, including all services performed by
health-care professionals (family doctor, surgeon, radiol-
ogist, psychiatrist, nurse, physiotherapist, etc.);
complementary charges, including pharmaceuticals,
transport, biological analysis, orthoses, etc.
The inclusive overall cost incurred by Sécurité Sociale
efore, during and after TDR was thus displayed for these
our main cost categories, as total gross sum and mean sum
er patient and per month, so as to enable the costs to be
eighted according to the individual period of follow-up.
he objective was to compare management costs before
nd after TDR. Overall, expenditure was also displayed per
pecialty and per period of follow-up.
Clinical, social and radiological risk factors were explored
or.
Statistical analysis used the non-parametric Mann-
hitney test (comparison of means) and Kruskall-Wallis test.
hen results on the latter were signiﬁcant, pairwise com-
arison (Mann-Whitney) was performed with a signiﬁcance
hreshold reduced to p = 0.01.
Quantitative variables were compared on the nonpara-
etric Spearman test, to identify correlations between
ndividual clinical and radiological parameters on the one
and and costs per patient and per month (divided by
he individual period of follow-up) on the other. The sig-
iﬁcance threshold was set at p = 0.05. Analyses were
erformed using STATVIEW 5 software (SAS Institute Inc.,
ary, NC).
esultslinical
here was one complication, at the beginning of our
xperience: an L5 posterior wall fracture sustained while
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Table 1 Gross reimbursements by the CPAM per patient over 39months.
Global cost
(D)
Pre-op cost
per month
(D)
Peri-op cost
for 4 months
(D)
Postop cost
per month
(D)
Pre-op FU
(Months)
Postop FU
(Months)
Post/pre-op
gain (%)
Satisfaction
Patient 1 6717 105 4737 40 9.1 25.7 Decrease 62 Very satisﬁed
Patient 2 7498 133 4860 53 10.1 24.7 Decrease 60 Very satisﬁed
Patient 3 10,593 196 5656 129 6.6 28.1 Decrease 34 Very satisﬁed
Patient 4 11,552 271 5613 91 15.4 19.3 Decrease 66 Satisﬁed
Patient 5 12,213 114 5832 258 17.9 16.8 Increase 125 Satisﬁed
Patient 6 12,504 169 6739 162 19.0 15.7 Decrease 4 Very satisﬁed
Patient 7 12,838 93 8373 140 8.5 26.3 Increase 51 Satisﬁed
Patient 8 14,039 287 6229 197 10.9 23.8 Decrease 31 Very satisﬁed
Patient 9 14,105 116 4877 314 8.5 26.3 Increase 171 Very satisﬁed
Patient 10 15,052 381 4416 208 19.8 15.0 Decrease 45 Disappointed
Patient 11 15,178 859 7467 157 3.2 31.5 Decrease 82 Very satisﬁed
Patient 12 22,076 747 5216 282 15.2 19.5 Decrease 62 Very disappointed (invalidity)
Patient 13 23,340 545 6788 393 19.0 15.7 Decrease 28 Satisﬁed
Patient 14 23,763 314 6438 742 19.7 15.0 Increase 137 Satisﬁed
Patient 15 29,639 1945 7267 324 6.9 27.9 Decrease 83 Very satisﬁed
Patient 16 32,788 1137 9120 579 6.4 28.3 Decrease 49 Very satisﬁed (invalidity)
Patient 17 38,164 367 11282 1652 23.7 11.0 Increase 350 Satisﬁed
Patient 18 41,013 836 6851 1056 11.4 23.3 Increase 26 Disappointed (invalidity)
Patient 19 56,009 1079 12057 1517 20.0 14.8 Increase 41 Disappointed (invalidity)
Sum 399,082 9694 129,818 8294 251 409
Mean 21,004 510 6833 437 13 22
Min 6717 93 4416 40 3 11
Max 56,009 1945 12,057 1652 24 32
SD 13,152 486 2111 477 6 6
The bold characters shows which patients are with invalidity, meaning secondary beneﬁts.
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Table 2 Distribution of total expenditure for the 3 follow-up periods.
In Euros Total over
39months’ FU
Pre-op over a
mean 13.2months’
FU
Peri-op over a
mean 4months’
FU
Postop over a
mean 21.5months’
FU
Number and cumulative
time of economic FU
n = 19;
736months’ FU
n = 19; 251months’
FU
n = 19;
76months’ FU
n = 19; 409months’
FU
Daily beneﬁt and
disability
compensation
153,466 61,533 16,082 75,851
Hospital stay 130,024 13,506 91,104 25,414
Pharmacy 42,900 17,145 5875 19,880
Radiology 17,072 5009 3943 8120
Physiotherapy 14,186 5969 2013 6203
General medicine 13,183 4811 1751 6621
Laboratory 11,497 4206 2817 4474
Ambulances 4240 817 2025 1398
Psychiatry 2231 1307 251 673
Orthopedic surgery 1862 249 1320 293
Physical medicine 1626 44 810 772
Nuclear medicine 1575 598 0 978
Nursing 1514 138 1101 276
Misc. Suppliers 1279 236 311 732
Anesthesiology 904 207 130 567
Rheumatology 777 661 23 93
Neurology 574 0 241 333
Neurosurgery 173 129 22 22
Total 399,082 116,565 129,818 152,699
Cost per patient per
month
542 464 1708 373
o rem
lPost-/pre-op gain
The bold characters show the most important numbers, the one t
introducing the implant. The patient showed a neurolog-
ical deﬁcit, and surgical revision with decompression was
performed on a posterior approach. At 2 years’ follow-up,
neurological recovery remained incomplete, with disabling
i
v
s
Figure 2 Cost distribution by−19%
ember.
ow back pain. Radiography at 2 years’ FU found an implant
mpacted in the L5 body with absence of spontaneous inter-
ertebral fusion. The patient was, at the time of writing,
uing the Nice University Hospital Center and refusing any
category and period of FU.
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Table 3 Medicoeconomic correlations.
(r = correlation coefﬁcient)a Pre-op costs Peri-op costs Post-op costs
Pre-op VAS/Oswestry/SF-36 NS NS NS
Postop VAS r = 0.66 p = 0.01 NS r = 0.62 p = 0.02
Postop Oswestry r = 0.69 p = 0.02 NS r = 0.67 p = 0.03
Postop SF36 r =−0.57 p = 0.03 NS r =−0.72 p = 0.003
Pre-op costs r = 0.52 p = 0.01 r = 0.61 p = 0.004
Peri-op costs NS r = 0.6 p = 0.005
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a Spearman test.
urgical revision. This case was excluded from the economic
nalysis.
Pain as assessed on the VAS fell from a mean 7.5 (± 2)
reoperatively to 3.9 (± 3) at 3 months’ FU and 3.6 (± 3) at
nd of follow-up (2 years postoperatively).
Mean Oswestry score fell from 46.6 (± 12) preoperatively
o 28.8 (± 20) at 3months’ FU and 25.2 (± 21) at end of
ollow-up; in mean global SF-36 score rose from 34.1 (± 10)
reoperatively to 64.5 (± 27) at 3months’ FU and 67.7 (± 26)
t end of follow-up (2 years postoperatively).
Eleven patients (59%) returned to work (including two to a
ower activity level job) and eight (41%) did not (4 on disabil-
ty compensation, one unemployed and three with persistent
ain).
Sixteen patients (84%) resumed sports activity (seven
ithout restriction and nine patients at a lower level than
oped) and three patients were unable to.
Fifteen patients (79%) resumed their household activity
including four at a lower level) and four did not.
Fifteen patients (79%) declared themselves very satis-
ed (n = 8) or satisﬁed (n = 7) with the operation; three were
isappointed and one very disappointed.
Four patients received disability compensation follow-
ng TDR; three of them were disappointed and one
as very satisﬁed with the result of the operation as
ompared to his preoperative condition. None of the dis-
atisﬁed patients agreed to surgical revision by posterior
usion.
conomic
he purchase of 19 implants cost D 46,959. Over the
9months of follow-up, the 19 patients totalled costs
f D 399,082 (excluding implants), or a mean D 21,004
er patient (range, D 6717—56,009). Table 1 and Fig. 1
resent total and period-based costs per patient. Five of
he 19 patients accounted for 50% of the total expen-
iture; three of the ﬁve were in receipt of disability
ompensation. Table 2 and Fig. 2 present results per
eriod and per specialty. Overall, management costs
er patient per month fell by 19% between the pre-
perative (D 464/mo/patient) and postoperative periods
D 373/mo/patient). The mean cost of TDR over the 4-
onth perioperative period was D 6,833 per patient (range,
4416—D12,057).
Daily beneﬁt was the prime cost in both pre- and postop-
rative periods. Hospital costs ranked second (except during
he perioperative period, when they were the main cost
tem).
s
f
sr = 0.68 p = 0.001 r = 0.58 p = 0.008
tatistics
here was no signiﬁcant correlation between preoperative
linical status and postoperative clinical result, or between
reoperative clinical status and preoperative costs, or
etween preoperative psychological status (SF-36) and post-
perative costs. Nor were there any signiﬁcant differences
ccording to gender, type of implant or radiological param-
ters (implant positioning or disc space reconstruction).
There were signiﬁcant correlations (Table 3) between:
ostoperative clinical status and postoperative costs; pre-
perative costs and postoperative clinical status; pre-, peri-
nd postoperative costs; and age and both post- and periop-
rative costs.
Satisﬁed patients showed lower costs than dissatisﬁed
atients.
iscussion
he present study concerned a small series at short follow-
p, but without loss to follow-up. The data collection
ethodology is reliable and reproducible, the IT request
rocedure in the CPAM database being standardized. The
xactitude of the economic data thereby retrieved is much
reater than would be the case using patient interviews.
he cost taken into account is technically a reimbursement,
pproximating the real cost of the service. The present
tudy was conducted before the so-called ‘‘act-based pric-
ng’’ (Tariﬁcation à l’Acte [T2A]) came into force in France,
aking the present results more rigorous inasmuch as no
eductible ﬁxed charges were involved. It is difﬁcult in
rance to come by reliable data for the real costs involved
n a given pathology, and in that context it is interesting to
evelop a methodology for assessing the real costs associ-
ted with a new health-care technique.
One case of vertebral fracture occurred at the begin-
ing of the present experience: the corresponding economic
ssessment represented not the cost of the TDR but that
f the surgical management of a complication. This type
f complication is reported elsewhere [3—8], and implant
esign has since improved so as to limit incidence.
Medicoeconomically, the present results conﬁrm that TDR
n our restricted indications achieves both clear clinical ben-
ﬁt and clear cost-saving (19%) on postoperative medical
are as compared to the preoperative period.Analysis of failure found that no patients agreed to revi-
ion using posterior fusion. This Patient’s attitude limiting
urther eventual improvement, cast some doubt on their
upposed dissatisfaction.
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It is important to identify pre-operative risk factors for
poor postoperative clinical and/or economic results with
the present procedure. No preoperative clinical or radio-
logical factors emerged as predictive of the postoperative
medicoeconomic result.
Preoperative cost, on the other hand, did correlate
signiﬁcantly with postoperative clinical result and with post-
operative cost, which in turn correlated with one another.
Satisﬁed patients showed lower postoperative costs and
more frequently returned to work. It may be concluded that
preoperative economic assessment is a good predictor of
postoperative clinical and economic results.
Analysis of the medicoeconomic data further found that
older patients had higher peri- and postoperative costs. The
older the patient is at surgery, the higher perhaps the risk
of posterior osteoarthritis (not necessarily prevented by the
interbody arthroplasty), or of anterior osteoarthritis at adja-
cent levels.
Seventy-ﬁve percent of patients with poor clinical results
were eligible for disability compensation, and daily bene-
ﬁt and disability compensation were found to predominate
in overall costs both pre- and postoperatively. The lit-
erature makes it clear that disability compensation is a
chronicity factor in chronic LBP, independently of treat-
ment option [9—11]. Moreover, the lack of anatomoclinical
correlation with diagnosis, so often reported in vertebral
surgery [12], applies equally to treatment inasmuch as ﬁnan-
cial beneﬁts are reported to induce discrepancy between
objective and subjective assessment in chronic LBP patients
[13—17]. Work accidents were excluded from the present
series, to limit the issue of side-beneﬁts [13—16,18—22];
on the other hand, our methodology, although based on
General provision Sécurité Sociale data, did not allow the
self-employed (4/30) to be included (this no doubt had
the effect of restoring the balance of the series in this
regard). Chronic LBP is a pathology in which the various
treatment options achieve only limited success, and in which
management is often costly, with a high rate of disability
compensation paid to young active patients. In this context,
it is especially worth looking into a treatment option able
to improve quality of life and socio-occupational integra-
tion.
The international literature reports wide methodologi-
cal heterogeneity, with different methods of assessing the
cost of medico-surgical management of chronic LBP. A liter-
ature search retrieved ‘‘market studies’’ [23], ‘‘economic
models’’ [24], ‘‘comparative studies’’ [25], many ‘‘cost-
effectiveness studies’’ [26,27], and ‘‘cost assessments’’
[28,29]. It is difﬁcult to make comparisons across health
systems and different systems of social insurance and
reimbursement. There are in fact ‘‘as many methods as
authors’’, making comparison between studies impossible.
Indeed, Soegaard et al. [30], in a review of the literature,
demonstrated that none of them are scientiﬁcally reliable.
We were not able to ﬁnd any medicoeconomic studies of
LBP in the literature that used a methodology comparable
to the present one.
In the French-language literature, Haumesser [31], in
2004, followed up 100 chronic LBP patients managed
by discectomy, using accountancy data from the Metz
CPAM. Mean global cost per patient was D 15,679 (range,
D 1769—47,876). Daily beneﬁts made up more than half of539
his, and were the main form of reimbursement. The present
esults were similar, as the target population was simi-
ar; disability compensation, however, was not taken into
ccount in Haumesser’s study, limiting the possibilities of
irect comparison.
Such medicoeconomic studies can only be interpreted in
heir own context: in a given country, in a given period.
n the present study, performed in 2007 under the French
écurité Sociale system, TDR represented a cost of D 6833
er patient over 4months of care (to which the cost of the
mplant itself has to be added). After the third postoperative
onth, costs varied according to clinical result.
The ﬁnancial impact of TDR is complex, as the available
pidemiological data for LBP are fragmentary, as pointed out
n the ANAES [32,33] and HAS [34] reports, which cautiously
stimated the potential target population at 600 to 6500
atients per year.
onclusion
edicoeconomic data are required in assessing our medical
ractices; it must not, however, be forgotten that the aim of
ny medical care is above all to improve the patient’s quality
f life: a purely economic perspective is to be resisted, as
t is all too liable to slip irremediably into abuse.
Surgical management of degenerative lumbar lesions is
lassically founded on intervertebral fusion; TDR, however,
ow extends treatment options in restricted indications.
The present study showed that TDR provides favorable
edical and economic outcomes, especially in young and
ctive chronic LBP patients.
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